Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Funder

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Endocrinology|April 22, 2006
Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt ratsEmily Y M Lam, John W Funder, David J Nikolic-Paterson, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2012
Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarctionThi Yen Loan Le, Mahidi Mardini, Viive M Howell, et al.
The Journal of Endocrinology|October 8, 2013
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivoIsabelle Vögeli, Hans H Jung, Bernhard Dick, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2016
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice GuidelineJohn W Funder, Robert M Carey, Franco Mantero, et al.
Regulatory Peptides|December 8, 2004
Glucocorticoid responses to stress in castrate and testosterone-replaced ramsTye Dawood, Maro R I Williams, Meryl J Fullerton, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activityJessica D Dietz, Sarah Du, Charles W Bolten, et al.
Endocrinology|January 16, 2014
Role of androgens in sex differences in cardiac damage during myocardial infarctionThi Y L Le, Anthony W Ashton, Mahidi Mardini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptorsMaro R I Williams, Tye Dawood, Shanhong Ling, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 2008
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelineJohn W Funder, Robert M Carey, Carlos Fardella, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Endocrinology|April 22, 2006
Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt ratsEmily Y M Lam, John W Funder, David J Nikolic-Paterson, et al.
Hypertension (Dallas, Tex. : 1979)|April 18, 2012
Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarctionThi Yen Loan Le, Mahidi Mardini, Viive M Howell, et al.
The Journal of Endocrinology|October 8, 2013
Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivoIsabelle Vögeli, Hans H Jung, Bernhard Dick, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2016
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice GuidelineJohn W Funder, Robert M Carey, Franco Mantero, et al.
Regulatory Peptides|December 8, 2004
Glucocorticoid responses to stress in castrate and testosterone-replaced ramsTye Dawood, Maro R I Williams, Meryl J Fullerton, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activityJessica D Dietz, Sarah Du, Charles W Bolten, et al.
Endocrinology|January 16, 2014
Role of androgens in sex differences in cardiac damage during myocardial infarctionThi Y L Le, Anthony W Ashton, Mahidi Mardini, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptorsMaro R I Williams, Tye Dawood, Shanhong Ling, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 2008
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelineJohn W Funder, Robert M Carey, Carlos Fardella, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
Pageof 14